To ascertain these hypotheses, further experiments are needed to determine whether sustained O-GlcNAcylation of GSK-3β could be involved in the increase of cyclin D1 stability in MCF7 and HCT116 cancer cells, as shown for FoxM1 in gastric cancer cells (48). Here, CCND1 is linked to cancer.